$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
雷利度胺在治疗多发性骨髓瘤这方面疗效如何?
2025-10-19 11:44:20
Check Details
雷利度胺治什么?
2025-10-19 11:44:20
Check Details
2020年雷利度胺售价多少?
2025-10-19 11:44:20
Check Details
雷利度胺是医保药吗?
2025-10-19 11:44:20
Check Details
雷利度胺对多发性骨髓瘤能有多大疗效?
2025-10-19 11:44:20
Check Details
雷利度胺获批的适应症有什么?
2025-10-19 11:44:20
Check Details
雷利度胺纳入医保目录了吗?
2025-10-19 11:44:20
Check Details
以万珂为基础的三联疗法“应继续”用于治疗新诊断的多发性骨髓瘤
2025-10-19 11:44:20
Check Details
伊沙佐米联合治疗多发性骨髓瘤显示13个月以上的PFS
2025-10-19 11:44:20
Check Details
马法兰针剂多少钱一支
2025-10-19 11:44:20
Check Details
马法兰香港哪里有卖
2025-10-19 11:44:20
Check Details
正规马法兰针剂价格是多少
2025-10-19 11:44:20
Check Details
1
2
...
1043
1044
1045
1046
1047
1048
1049
...
4157
4158
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
2
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
3
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
4
Cabozantinib Capsules: A Multi-Targeted Therapy for Progressive Medullary Thyroid Cancer
5
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
6
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
7
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration
8
Mitotane for Adrenocortical Carcinoma: Dosing Guidelines and Therapeutic Drug Monitoring
9
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
10
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
11
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
12
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer